Why the study?
Does prophylactic ICD therapy reduce sudden cardiac death in dialysis patients aged 55-80 years?
Population
200 dialysis patients aged 55-80 years
Design
Randomised
Follow-up
mean 4 years
Authors
Loading...
First pilot data on prophylactic ICD in dialysis; leaves open its efficacy for primary SCD prevention and requires randomized confirmation.
Does prophylactic ICD therapy reduce sudden cardiac death in dialysis patients aged 55-80 years?
The ICD2 trial is a prospective pilot study designed to be the first to evaluate the benefit of prophylactic ICD therapy for primary prevention of sudden cardiac death in dialysis patients.
Bie et al. (2008) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: